Lundbeck sells rights to three development programs
Danish pharmaceutical firm Lundbeck and Hong Kong-based Neuro3 Therapeutics have shaken hands on a fresh license and option agreement.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck and Otsuka win FDA approval for schizophrenia drug
For subscribers